2005 to 2008 we observed the largest number of deals in Biotechnology front, but after the recession there were very less number of deals, acquisition and partnership in this front, but analyst are still having the hope that 2013 we will have more number of deals in the Biotechnology front...As there is a lot of speculation that by 2020 the market for biologics in expected to be 60 Billion USD and the Biosimilar will capture market of more than $6 Billion. We need to see....last week we heard that Amgen has gone ahead to start with a new biotech startup and Novartis like its competitors in establishing its Biological unit in South Asia...
As last year J&J, Roche have already gone ahead to form their base, after china, Singapore as biotech hub, will India become the next biotech hub going forward?
But will this Biotech boom exist in Asia for long as it has started fading away from its sunshine in US and Europe?
As last year J&J, Roche have already gone ahead to form their base, after china, Singapore as biotech hub, will India become the next biotech hub going forward?
But will this Biotech boom exist in Asia for long as it has started fading away from its sunshine in US and Europe?
No comments:
Post a Comment